AnaptysBio (ANAB) Q3 2022 Earnings Report
0 Followers
MX:ANAB Q3 2022 EPS Results
- Actual EPS
- -MXN 14.60
- Consensus EPS
- -MXN 16.20
- Beat/Miss
- Beat by +MXN 1.60
- One Year Ago EPS
- -MXN 2.97
MX:ANAB Q3 2022 Revenue Results
- Actual Revenue
- MXN 23.99M
- Expected Revenue
- MXN 18.00M
- Beat/Miss
- Beat by +MXN 5.99M
- YoY Revenue Growth
- -93.81%
Earnings Announcement Details
- Quarter
- Q3 2022
- Date
- 11/08/2022
- Time
- After Close
- Conference Call
- Tuesday, November 8, 2022
MX:ANAB Upcoming Earnings
AnaptysBio's next earnings date is estimated for November 10, 2026, based on past reporting schedules.
Q3 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:ANAB Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 10, 2026 | 2026 (Q3) | -34.14-34.14 | 9.67 | -453.17% (-43.81) | ― |
| Sep 21, 2026 | 2026 (Q2) | -16.57-16.57 | -16.57 | 0.00% (+0.00) | |
| May 12, 2026 | 2026 (Q1) | 6.44-15.83 | -23.81 | 33.52% (+7.98) | |
| Mar 03, 2026 | 2025 (Q4) | -16.5729.37 | -8.91 | 429.79% (+38.28) | |
| Nov 04, 2025 | 2025 (Q3) | -15.839.67 | -14.1 | 168.55% (+23.77) | |
| Aug 06, 2025 | 2025 (Q2) | -8.91-24.88 | -21.15 | -17.63% (-3.73) | |
| May 05, 2025 | 2025 (Q1) | -14.10-23.81 | -20.28 | -17.38% (-3.53) | |
| Feb 27, 2025 | 2024 (Q4) | -20.02-8.91 | -19.67 | 54.72% (+10.76) | |
| Nov 05, 2024 | 2024 (Q3) | -20.37-14.10 | -17.44 | 19.15% (+3.34) | |
| Aug 05, 2024 | 2024 (Q2) | -12.88-21.15 | -18.56 | -14.00% (-2.60) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
